You have to always bear in mind there will be entities in the Western world who don't want a successful treatment for SCA simply because it will create a huge loss of revenue for hospitals and major pharmaceutical companies. A billion $ a year is big business.
Makes you wonder how much savings it would amount to if Nicosan is used instead of using the current treatments. Once the figures are crunched out, you would think that the insurance companies would be more than happy to embrace Nicosan as the #1 drug of choice in treatment and in prevention.
News 
Market Data 
Discover 
AI
